Scarica l'app Stockscreener
40.91
12.24%
4.46
Dopo l'orario di chiusura:
40.95
0.04
+0.10%
Precedente Chiudi:
$36.45
Aprire:
$37.12
Volume 24 ore:
343.09K
Relative Volume:
1.53
Capitalizzazione di mercato:
$384.18M
Reddito:
-
Utile/perdita netta:
$-81.17M
Rapporto P/E:
-4.0367
EPS:
-10.1344
Flusso di cassa netto:
$-82.84M
1 W Prestazione:
+7.40%
1M Prestazione:
-14.58%
6M Prestazione:
+130.48%
1 anno Prestazione:
-28.85%
Intervallo 1D:
$36.01
$42.70
Intervallo di 1 settimana:
$36.01
$42.70
Portata 52W:
$10.29
$76.79
Korro Bio Inc Stock (KRRO) Company Profile
Nome
Korro Bio Inc
Settore
Industria
Telefono
617-468-1999
Indirizzo
60 FIRST STREET, CAMBRIDGE
Confronta KRRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
40.91 | 342.30M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-10 | Iniziato | Oppenheimer | Outperform |
| 2024-10-21 | Iniziato | Raymond James | Strong Buy |
| 2024-08-14 | Iniziato | William Blair | Outperform |
| 2024-03-28 | Reiterato | H.C. Wainwright | Buy |
| 2024-02-27 | Iniziato | BMO Capital Markets | Outperform |
| 2023-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-11-10 | Iniziato | Piper Sandler | Overweight |
| 2023-02-15 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Downgrade | Cowen | Outperform → Market Perform |
| 2021-09-22 | Downgrade | Goldman | Buy → Neutral |
| 2021-01-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Iniziato | B. Riley Securities | Buy |
| 2020-07-14 | Iniziato | Oppenheimer | Outperform |
| 2020-05-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Iniziato | Cowen | Outperform |
| 2019-10-28 | Iniziato | Goldman | Buy |
| 2019-10-28 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Korro Bio Inc Borsa (KRRO) Ultime notizie
Will Korro Bio Inc. stock recover faster than market2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Automated trading signals detected on Korro Bio Inc.Market Activity Report & Consistent Profit Trading Strategies - newser.com
Can Korro Bio Inc. stock double in next 5 yearsJuly 2025 Weekly Recap & Real-Time Chart Pattern Alerts - newser.com
Why Korro Bio Inc. stock is favored by pension fundsPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Trend analysis for Korro Bio Inc. this weekEarnings Overview Summary & Weekly Top Stock Performers List - newser.com
Korro Bio’s KRRO-110 Study: A Potential Game-Changer in Genetic Therapy - MSN
Published on: 2025-11-01 04:19:56 - newser.com
Will Korro Bio Inc. stock deliver strong dividend growthWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
Why retail investors pile into Korro Bio Inc. stockJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
What high frequency data says about Korro Bio Inc.2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
How to track smart money flows in Korro Bio Inc.2025 Performance Recap & Risk Managed Trade Strategies - newser.com
Risk vs reward if holding onto Korro Bio Inc.Market Activity Report & High Accuracy Buy Signal Tips - newser.com
Clear Street Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - Nasdaq
This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
What makes Korro Bio Inc. stock attractive to growth fundsJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com
Key resistance and support levels for Korro Bio Inc.July 2025 PostEarnings & Detailed Earnings Play Strategies - newser.com
Custom strategy builders for tracking Korro Bio Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Will Korro Bio Inc. stock attract more institutional investorsJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Clear Street initiates Korro Bio stock with Buy rating, $93 price target - Investing.com Canada
Clear Street initiates Korro Bio stock with Buy rating, $93 price target By Investing.com - Investing.com South Africa
What analysts say about Korro Bio Inc stockInflation Impact on Stocks & Free Rapid Return Acceleration - earlytimes.in
Is Korro Bio Inc. stock positioned for long term growthQuarterly Market Review & Low Volatility Stock Recommendations - newser.com
Korro Bio Inc Azioni (KRRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):